Howard M Sandler - JoVE Visualize

Showing results (201-210 of 234) with videos related to

Pageof 24

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyJulie Gralow, Robert F Ozols, Dean F Bajorin, et al.

Plos One|April 14, 2021

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.

European Urology Focus|February 2, 2024

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.

The New England Journal of Medicine|February 2, 2017

Radiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized TrialBenjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020

Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.

European Urology|November 14, 2019

Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.

International Journal of Radiation Oncology, Biology, Physics|February 9, 2026

Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.

JCO Clinical Cancer Informatics|May 9, 2025

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.

Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:

Pageof 24

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyJulie Gralow, Robert F Ozols, Dean F Bajorin, et al.

Plos One|April 14, 2021

Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.

European Urology Focus|February 2, 2024

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.

The New England Journal of Medicine|February 2, 2017

Radiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized TrialBenjamin Movsas, Joseph P Rodgers, Mohamed A Elshaikh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020

Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025

Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.

European Urology|November 14, 2019

Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.

International Journal of Radiation Oncology, Biology, Physics|February 9, 2026

Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.

JCO Clinical Cancer Informatics|May 9, 2025

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.

Pageof 24